These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 21898547

  • 1. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
    Kim JL, Kang SW, Kang MK, Gong JH, Lee ES, Han SJ, Kang YH.
    J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
    [Abstract] [Full Text] [Related]

  • 2. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
    Kim JL, Kang MK, Gong JH, Park SH, Han SY, Kang YH.
    Mol Nutr Food Res; 2012 Aug; 56(8):1223-33. PubMed ID: 22700286
    [Abstract] [Full Text] [Related]

  • 3. Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.
    Kim JL, Park SH, Jeong D, Nam JS, Kang YH.
    Exp Biol Med (Maywood); 2012 Apr; 237(4):417-28. PubMed ID: 22496431
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Osteogenic activity of yellow flag iris (Iris pseudacorus) extract modulating differentiation of osteoblasts and osteoclasts.
    Kim JL, Li HM, Kim YH, Lee YJ, Shim JH, Lim SS, Kang YH.
    Am J Chin Med; 2012 Apr; 40(6):1289-305. PubMed ID: 23227798
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
    Li L, Sapkota M, Gao M, Choi H, Soh Y.
    Eur J Pharmacol; 2017 Nov 15; 815():202-209. PubMed ID: 28919027
    [Abstract] [Full Text] [Related]

  • 8. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X, Li X, Zhai X, Zhi X, Cao L, Qin L, Su J.
    Cell Physiol Biochem; 2018 Nov 15; 51(6):2858-2871. PubMed ID: 30562759
    [Abstract] [Full Text] [Related]

  • 9. Antiosteoclastogenic activity of silicate-based materials antagonizing receptor activator for nuclear factor kappaB ligand-induced osteoclast differentiation of murine marcophages.
    Hung CJ, Kao CT, Chen YJ, Shie MY, Huang TH.
    J Endod; 2013 Dec 15; 39(12):1557-61. PubMed ID: 24238446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W, Dou H, Liu X, Sun L, Hou Y.
    Clin Exp Pharmacol Physiol; 2012 Oct 15; 39(10):886-93. PubMed ID: 23013134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antitumor agent cabozantinib decreases RANKL expression in osteoblastic cells and inhibits osteoclastogenesis and PTHrP-stimulated bone resorption.
    Stern PH, Alvares K.
    J Cell Biochem; 2014 Nov 15; 115(11):2033-8. PubMed ID: 25042887
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M.
    J Bone Miner Res; 2011 Mar 15; 26(3):644-56. PubMed ID: 20814972
    [Abstract] [Full Text] [Related]

  • 16. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
    Xu F, Dong Y, Huang X, Chen P, Guo F, Chen A, Huang S.
    Mol Med Rep; 2016 Sep 15; 14(3):2289-96. PubMed ID: 27430581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.